Live Biotherapeutic to Augment Response to Immunotherapy
A novel strain of E. Coli capable of inducing TH17 T cells to improve immune response
Published: 29th October 2019
Please note, header image is purely illustrative. Source: Elevate, unsplash license
Patent application submitted
An online matchmaking platform for university-industry collaboration.